4//SEC Filing
CoLucid Pharmaceuticals, Inc. 4
Accession 0000911916-15-000187
CIK 0001348649operating
Filed
May 11, 8:00 PM ET
Accepted
May 12, 5:22 PM ET
Size
22.8 KB
Accession
0000911916-15-000187
Insider Transaction Report
Form 4
Markham Richard J
Director10% Owner
Transactions
- Conversion
Series C Convertible Preferred Stock
2015-05-11−320,295→ 0 total(indirect: By Care Capital Investments III, LP)→ Common Stock (320,295 underlying) - Conversion
Series C Convertible Preferred Stock
2015-05-11−5,353→ 0 total(indirect: By Care Capital Offshore Investments III, LP)→ Common Stock (5,353 underlying) - Conversion
Common Stock
2015-05-11+1,520,136→ 1,520,136 total(indirect: By Care Capital Investments III, LP) - Conversion
Common Stock
2015-05-11+25,403→ 25,403 total(indirect: By Care Capital Offshore Investments III, LP) - Conversion
Series B Convertible Preferred Stock
2015-05-11−1,199,841→ 0 total(indirect: By Care Capital Investments III, LP)→ Common Stock (1,199,841 underlying) - Conversion
Series B Convertible Preferred Stock
2015-05-11−20,050→ 0 total(indirect: By Care Capital Offshore Investments III, LP)→ Common Stock (20,050 underlying)
Care Capital Investments III L.P.
10% Owner
Transactions
- Conversion
Common Stock
2015-05-11+25,403→ 25,403 total(indirect: By Care Capital Offshore Investments III, LP) - Conversion
Series B Convertible Preferred Stock
2015-05-11−1,199,841→ 0 total(indirect: By Care Capital Investments III, LP)→ Common Stock (1,199,841 underlying) - Conversion
Series C Convertible Preferred Stock
2015-05-11−5,353→ 0 total(indirect: By Care Capital Offshore Investments III, LP)→ Common Stock (5,353 underlying) - Conversion
Common Stock
2015-05-11+1,520,136→ 1,520,136 total(indirect: By Care Capital Investments III, LP) - Conversion
Series B Convertible Preferred Stock
2015-05-11−20,050→ 0 total(indirect: By Care Capital Offshore Investments III, LP)→ Common Stock (20,050 underlying) - Conversion
Series C Convertible Preferred Stock
2015-05-11−320,295→ 0 total(indirect: By Care Capital Investments III, LP)→ Common Stock (320,295 underlying)
Transactions
- Conversion
Series C Convertible Preferred Stock
2015-05-11−5,353→ 0 total(indirect: By Care Capital Offshore Investments III, LP)→ Common Stock (5,353 underlying) - Conversion
Common Stock
2015-05-11+25,403→ 25,403 total(indirect: By Care Capital Offshore Investments III, LP) - Conversion
Series B Convertible Preferred Stock
2015-05-11−20,050→ 0 total(indirect: By Care Capital Offshore Investments III, LP)→ Common Stock (20,050 underlying) - Conversion
Common Stock
2015-05-11+1,520,136→ 1,520,136 total(indirect: By Care Capital Investments III, LP) - Conversion
Series B Convertible Preferred Stock
2015-05-11−1,199,841→ 0 total(indirect: By Care Capital Investments III, LP)→ Common Stock (1,199,841 underlying) - Conversion
Series C Convertible Preferred Stock
2015-05-11−320,295→ 0 total(indirect: By Care Capital Investments III, LP)→ Common Stock (320,295 underlying)
Care Capital III LLC
10% Owner
Transactions
- Conversion
Series B Convertible Preferred Stock
2015-05-11−1,199,841→ 0 total(indirect: By Care Capital Investments III, LP)→ Common Stock (1,199,841 underlying) - Conversion
Series C Convertible Preferred Stock
2015-05-11−320,295→ 0 total(indirect: By Care Capital Investments III, LP)→ Common Stock (320,295 underlying) - Conversion
Common Stock
2015-05-11+1,520,136→ 1,520,136 total(indirect: By Care Capital Investments III, LP) - Conversion
Common Stock
2015-05-11+25,403→ 25,403 total(indirect: By Care Capital Offshore Investments III, LP) - Conversion
Series B Convertible Preferred Stock
2015-05-11−20,050→ 0 total(indirect: By Care Capital Offshore Investments III, LP)→ Common Stock (20,050 underlying) - Conversion
Series C Convertible Preferred Stock
2015-05-11−5,353→ 0 total(indirect: By Care Capital Offshore Investments III, LP)→ Common Stock (5,353 underlying)
Footnotes (5)
- [F1]Each share of Series B and Series C Convertible Preferred Stock was convertible at any time at the option of the holder, and converted automatically into shares of the Issuer's Common Stock on a one-for-one basis in connection with the closing of the Issuer's initial public offering.
- [F2]Care Capital III LLC is the general partner of Care Capital Investments III LP and Care Capital Offshore Investments III LP and as a result, Care Capital III LLC has the ultimate power to vote or direct the vote and to dispose or direct the disposition of such shares. Richard Markham, Jan Leschly, Jerry N. Karabelas and David R. Ramsay are the four managing members at Care Capital III LLC, and in their capacity as such, may be deemed to exercise shared voting and investment power over the shares held by the reporting persons, each of whom disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- [F3]Represents securities held directly by Care Capital Investments III, LP. The reporting person is a partner in Care Capital Investments III, L.P., and shares voting and investment power with the other partners with respect to all of these shares. The reporting person may be deemed to be an indirect beneficial owner of the reported securities. The reporting person disclaims any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F4]Represents securities held directly by Care Capital Offshore Investments III, LP, an affiliate of Care Capital Investments III, LP. The reporting person is a partner in Care Capital Investments III, L.P., and shares voting and investment power with the other partners with respect to all of these shares. The reporting person may be deemed to be an indirect beneficial owner of the reported securities. The reporting person disclaims any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F5]The securities did not have an expiration date. The securities converted automatically into shares of the Issuer's Common Stock on a one-for-one basis in connection with the closing of the Issuer's initial public offering.
Documents
Issuer
CoLucid Pharmaceuticals, Inc.
CIK 0001348649
Entity typeoperating
Related Parties
1- filerCIK 0001348649
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 5:22 PM ET
- Size
- 22.8 KB